Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 1-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | HCID 2773987 | — |
| Reactant | HCID 51357234 | HCID 51357234 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Solvent | 1,2-Dimethoxyethane | HCID 8071 | — |
| Product | HCID 69936548 | HCID 69936548 | — |
Reaction Steps
To a microwave vial was added 5-bromo-2-({[2-(methyloxy)phenyl]methyl}oxy)-N-3-pyridinylbenzamide (may be prepared as described in example 21; 115 mg, 0.28 mmol), 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (63.7 mg, 0.31 mmol), 1,2-dimethoxyethane (2 ml), 1M sodium carbonate (0.56 ml, 0.56 mmol) and tetrakis(triphenylphosphine)palladium(0) (19.29 mg, 0.02 mmol). The vial was sealed and heated to 120° C. for 1 hr under microwave conditions. The mixture was evaporated under reduced pressure. Water (5 ml) was added to the residue and the mixture was extracted with ethyl acetate (3×10 ml). The organics were combined, evaporated under reduced pressure and the residue was purified using MDAP to yield the title compound. 10 mg.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08778939B2 |
|---|
| Source dataset | uspto-grants-2014_07 |
|---|
| ORD ID | ord-c8979cab499d4e5fad0910944d54c8cd |
|---|
| Source note | uspto-grants-2014_07 |
|---|